Heart transplant recipients
Heart transplant recipients are maintained on chronic immunosuppression (commonly tacrolimus or cyclosporine ± mycophenolate/azathioprine ± steroids). Dental relevance: (1) higher infection risk especially if neutropenic or early post-transplant/high-dose immunosuppression, (2) significant drug–drug interactions with common dental antibiotics/analgesics (calcineurin inhibitors are CYP3A4 substrates), and (3) a specific subset qualifies for IE prophylaxis — cardiac transplant with valve regurgitation due to structurally abnormal valve.
The full condition entry includes
- Safe vs avoid lists: antibiotics, analgesics, local anesthetics
- Vasoconstrictor limits and treatment modifications
- Pre/intra/post-op monitoring and deferral criteria
- Emergency management, explained for study
More medical conditions in dentistry
Dentalverse is an educational resource for dental students and dentists. This page is a study reference — it is not medical advice and does not replace clinical judgment. Always follow your institution's protocols and your supervisor's guidance.